|
시장보고서
상품코드
1958970
핵의학 영상 장치 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Nuclear Imaging Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
핵의학 영상 장치 시장 규모는 2025년 39억 3,000만 달러에서 2034년에는 69억 1,000만 달러에 이를 것으로 예측되며, 2026-2034년 CAGR 6.48%를 나타낼 전망입니다.
의료 기술의 발전과 의료 수요 증가로 인해 정확한 진단 도구의 필요성이 증가함에 따라 핵의학 영상진단기기 시장은 괄목할만한 성장이 예상됩니다. 방사성 물질을 이용하여 장기와 조직의 기능을 시각화하는 핵의학 영상은 다양한 질환의 진단과 관리에 필수적인 요소로 자리 잡고 있습니다. 전 세계 고령화와 만성질환 유병률 증가에 따라 핵의학 영상진단 장비에 대한 수요가 증가하여 시장 확대를 견인할 것으로 예측됩니다.
기술 혁신은 핵의학 영상진단 장비의 기능 향상에 중요한 역할을 하고 있습니다. 양전자방출단층촬영(PET), 단일광자방출단층촬영(SPECT) 등 영상기술의 발전으로 진단영상의 정확도와 해상도가 향상되고 있습니다. 이러한 발전으로 의료진은 질병을 조기에 발견할 수 있게 되었고, 이는 환자의 치료 결과를 개선하는 데 도움이 되고 있습니다. 또한, 핵의학 영상진단에 인공지능(AI)과 머신러닝을 통합하여 영상 분석과 해석을 효율화함으로써 진단 프로세스의 효율성을 더욱 향상시키고 있습니다. 이러한 기술이 계속 발전함에 따라 핵의학 영상진단 장비 시장은 의료 서비스 제공업체와 제조업체로부터 많은 투자를 유치할 가능성이 높습니다.
또한, 개인 맞춤형 의료와 표적치료에 대한 관심이 높아지는 것도 핵의학 영상진단기기 시장의 성장에 영향을 미치고 있습니다. 의료가 보다 개인화된 치료 접근 방식으로 전환함에 따라 정밀한 진단 도구의 필요성이 매우 중요해지고 있습니다. 핵의학 영상진단 장비는 환자별 질환에 대한 귀중한 정보를 제공하여 개인별 맞춤 치료 계획을 수립할 수 있도록 도와줍니다. 또한, 조기발견과 예방의료에 대한 중요성이 높아지면서 핵의학 영상기술의 채택을 촉진하고 있습니다. 시장이 진화함에 따라 핵의학 영상과 다른 진단 방법과의 통합은 새로운 기회를 창출하고 이 역동적인 분야의 성장을 더욱 가속화할 것으로 예측됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 핵의학 영상 장치 시장 : 제품 유형별
제5장 세계의 핵의학 영상 장치 시장 : 용도별
제6장 세계의 핵의학 영상 장치 시장 : 최종사용자별
제7장 세계의 핵의학 영상 장치 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
LSH 26.03.13The Nuclear Imaging Devices Market size is expected to reach USD 6.91 Billion in 2034 from USD 3.93 Billion (2025) growing at a CAGR of 6.48% during 2026-2034.
The Nuclear Imaging Devices Market is anticipated to witness significant growth as advancements in medical technology and increasing healthcare demands drive the need for accurate diagnostic tools. Nuclear imaging, which utilizes radioactive materials to visualize the functioning of organs and tissues, is becoming an essential component in the diagnosis and management of various medical conditions. As the global population ages and the prevalence of chronic diseases rises, the demand for nuclear imaging devices is expected to increase, propelling market expansion.
Technological innovations are playing a crucial role in enhancing the capabilities of nuclear imaging devices. Developments in imaging techniques, such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), are improving the accuracy and resolution of diagnostic images. These advancements enable healthcare professionals to detect diseases at earlier stages, leading to better patient outcomes. Additionally, the integration of artificial intelligence and machine learning in nuclear imaging is streamlining image analysis and interpretation, further enhancing the efficiency of diagnostic processes. As these technologies continue to evolve, the nuclear imaging devices market is likely to attract significant investments from healthcare providers and manufacturers.
Moreover, the increasing focus on personalized medicine and targeted therapies is influencing the growth of the nuclear imaging devices market. As healthcare shifts towards more individualized treatment approaches, the need for precise diagnostic tools becomes paramount. Nuclear imaging devices provide valuable insights into patient-specific conditions, allowing for tailored treatment plans. Furthermore, the growing emphasis on early detection and preventive healthcare is driving the adoption of nuclear imaging technologies. As the market evolves, the integration of nuclear imaging with other diagnostic modalities is expected to create new opportunities, further fueling growth in this dynamic sector.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product Type
- PET Devices
- SPECT Devices
- Planar Imaging Devices
By Application
- Oncology
- Cardiology
- Neurology
- Others (Nephrology, Immunology, etc.)
By End-User
- Hospitals
- Imaging Centers
- Academic And Research Centers
- Others (Clinics, CROs, Etc.)
COMPANIES PROFILED
- Koninklijke Philips NV, GE HealthCare Technologies Inc, Siemens Healthineers AG, Canon Medical Systems Corporation, Shimadzu Corporation, United Imaging Healthcare Co, MR Solutions, Cubresa Inc, Neusoft Medical Systems Co Ltd, Mediso Ltd, MIE GmbH, Others
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. PET Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. SPECT Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Planar Imaging Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Others (Nephrology, Immunology, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY END-USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End-user
- 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Academic And Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Others (Clinics, CROs, Etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End-user
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End-user
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End-user
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End-user
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End-user
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL NUCLEAR IMAGING DEVICES INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Koninklijke Philips N.V
- 9.2.2 GE HealthCare Technologies Inc
- 9.2.3 Siemens Healthineers AG
- 9.2.4 Canon Medical Systems Corporation
- 9.2.5 Shimadzu Corporation
- 9.2.6 United Imaging Healthcare Co
- 9.2.7 MR Solutions
- 9.2.8 Cubresa Inc
- 9.2.9 Neusoft Medical Systems Co. Ltd
- 9.2.10 Mediso Ltd
- 9.2.11 MIE GmbH
- 9.2.12 Others
